Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.
Jan 2011 - Blood; 117(2):1528-0020 [PMID:21030562]
[Rosenblatt J] [Vasir B] [Uhl L] [Blotta S] [Macnamara C] [Somaiya P] [Wu Z] [Joyce R] [Levine JD] [Dombagoda D] [Yuan YE] [Francoeur K] [Fitzgerald D] [Richardson P] [Weller E] [Anderson K] [Kufe D] [Munshi N] [Avigan D]

Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28.
Feb 2010 - :1537-4513 [PMID:20145548]
[Rosenblatt J] [Wu Z] [Vasir B] [Zarwan C] [Stone R] [Mills H] [Friedman T] [Konstantinopoulos PA] [Spentzos D] [Ghebremichael M] [Stevenson K] [Neuberg D] [Levine JD] [Joyce R] [Tzachanis D] [Boussiotis V] [Kufe D] [Avigan D]

Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells.
Jun 2008 - J. Immunol.; 181(1):0022-1767 [PMID:18566447]
[Vasir B] [Wu Z] [Crawford K] [Rosenblatt J] [Zarwan C] [Bissonnette A] [Kufe D] [Avigan D]

Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses.
Jul 2004 - Clin. Cancer Res.; 10(14):1078-0432 [PMID:15269142]
[Avigan D] [Vasir B] [Gong J] [Borges V] [Wu Z] [Uhl L] [Atkins M] [Mier J] [McDermott D] [Smith T] [Giallambardo N] [Stone C] [Schadt K] [Dolgoff J] [Tetreault JC] [Villarroel M] [Kufe D]